The site of the Media Sphera Publishers contains materials intended solely for healthcare professionals.
By closing this message, you confirm that you are a certified medical professional or a student of a medical educational institution.

Shavlovskaya O.A.

International University of Restorative Medicine», Moscow, Russia

Bokova I.A.

Sechenov First Moscow State Medical University (Sechenov University)

Asthenic disorders correction with Recognan

Authors:

Shavlovskaya O.A., Bokova I.A.

More about the authors

Read: 2422 times


To cite this article:

Shavlovskaya OA, Bokova IA. Asthenic disorders correction with Recognan. S.S. Korsakov Journal of Neurology and Psychiatry. 2024;124(3):57‑62. (In Russ.)
https://doi.org/10.17116/jnevro202412403157

Recommended articles:
Cognitive impairment in patients with Parkinson’s disease. S.S. Korsakov Journal of Neurology and Psychiatry. 2024;(11):81-90
Cognitive impairment in bili­nguals with neurological diseases. S.S. Korsakov Journal of Neurology and Psychiatry. 2024;(12):26-29
Modern aspe­cts of chro­nic cere­bral ischemia pathogenetic therapy. S.S. Korsakov Journal of Neurology and Psychiatry. 2024;(12):106-113
Non-invasive biomarkers for early diagnosis of Alzheimer’s disease in bodily fluids. S.S. Korsakov Journal of Neurology and Psychiatry. 2025;(1):8-16
Effi­cacy and safety of fonturacetam in asthenia: a systematic review and meta-analysis. S.S. Korsakov Journal of Neurology and Psychiatry. 2025;(2):69-79
Asthenia in the acute period of ischemic stroke. S.S. Korsakov Journal of Neurology and Psychiatry. 2025;(3-2):5-10
Differentiated approach to cognitive reha­bilitation of patients after stroke. Problems of Balneology, Physiotherapy and Exercise Therapy. 2024;(6):5-11

References:

  1. Sirotko ML, Denisenko MB, Zolotovskaya IA, Komarova MV. Frequency of selected chronic noncommunicable diseases in older patients with senile asthenia syndrome. Adv Gerontol. 2023;36(2):198-205. (In Russ.). https://doi.org/10.34922/AE.2023.36.2.006
  2. Tarasova IV, Sosnina AS, Kupriyanova DS, et al. Cognitive impairment in patients of cardiac surgery with senile asthenia syndrome and preastenia. Zhurnal Nevrologii i Psikhiatrii im S.S. Korsakova. 2023;123(11):57-63. (In Russ.). https://doi.org/10.17116/jnevro202312311157
  3. Senile asthenia. Clinical guidelines, 2021. (In Russ.). https://cr.minzdrav.gov.ru/recomend/613_1
  4. Tkacheva ON, Kotovskaya YuV, Runihina NK, et al. Comprehensive geriatric assessment in elderly and senile patients with cardiovascular diseases. Expert opinion of the Russian Association of Gerontologists and Geriatricians. Kardiologiia. 2021;61(5):71-78. (In Russ.). https://doi.org/10.18087/cardio.2021.5.n1349
  5. Dyukova GM. Asthenic syndrome: problems of diagnosis and therapy. Effective Pharmacotherapy. 2012;1:40-45. (In Russ.).
  6. Shavlovskaya OA. Therapy of asthenic conditions in stroke patients. Pharmateca. 2013;19(272):56-61. (In Russ.).
  7. Bogaevskaya OYu. Diagnostic approaches to the assessment of chronic fatigue syndrome/myalgic encephalomyelitis and tools to collect data on symptoms. Bulletin of Postgraduate Medical Education. 2020;1:50-53. (In Russ.).
  8. Chutko LS, Surushkina SYu, Iakovenko EA, et al. Disturbances of executive functions in children with emotional and behavioral dysregulation. Zhurnal Nevrologii i Psikhiatrii im. S.S. Korsakova. 2020;120(4):23-28. (In Russ.). https://doi.org/10.17116/jnevro202012004123
  9. Zolotovskaia IA, Shatskaia PR, Davydkin IL, Shavlovskaya OA. Post-COVID-19 asthenic syndrome. Zhurnal Nevrologii i Psikhiatrii im. S.S. Korsakova. 2021;121(4):25-30. (In Russ.). https://doi.org/10.17116/jnevro202112104125
  10. Khaibullina DKh, Maksimov YN. Asthenic post-COVID syndrome. Zhurnal Nevrologii i Psikhiatrii im. S.S. Korsakova. 2023;123(3):61-69. (In Russ.). https://doi.org/10.17116/jnevro202312303161
  11. Auxéméry Y. The Gulf War Syndrome twenty years. L’Encéphale. 2013;39:332-338.  https://doi.org/10.1016/j.encep.2012.11.003
  12. Kodali M, Jankay T, Shett AK. Pathophysiological basis and promise of experimental therapies for Gulf War Illness, a chronic neuropsychiatric syndrome in veterans. Psychopharmacology (Berl). 2023;240(4):673-697.  https://doi.org/10.1007/s00213-023-06319-5
  13. Teichman R. Exposures of concern to veterans returning from Afghanistan and Iraq. J Occup Environ Med. 2012;54(6):677-681.  https://doi.org/10.1097/JOM.0b013e318259c1ce
  14. Alishev NV, Tsygan VN, Drabkin BA, et al. Psychoemotional stress and somatic diseases in veterans of special risk units. Adv Gerontol. 2008;21(2):276-285. (In Russ.).
  15. Saverskaya EN. Of neurological disorders in extreme conditions and emergency situations. Zhurnal Nevrologii i Psikhiatrii im. S.S. Korsakova. 2022;122(12):57-62. (In Russ.). https://doi.org/10.17116/jnevro202212212157
  16. Vasileva TP, Yakushin MA, Makarova EV, et al. Executive functions and quality of life of Russian scientists. Eur J Transl Myol. 2021;31(2):9744. https://doi.org/10.4081/ejtm.2021.9744
  17. Temporary guidelines «Prevention, diagnosis and treatment of new coronavirus infection (COVID-19)». Version 18 (10/26/2023). (In Russ.). static-0.minzdrav.gov.ru
  18. Petrova LV, Kostenko EV, Eneeva MA. Asthenia and Post-COVID Syndrome: Pathogenesis, Clinical Presentations, Diagnosis, and Medical Rehabilitation. Doctor.Ru. 2021;20(9):36-42. (In Russ.). https://doi.org/10.31550/1727-2378-2021-20-9-36-42
  19. Perisse A, De Cacqueray F, Delarbre D, et al. Symptoms of Long-COVID 1-Year after a COVID-19 outbreak among sailors on a French aircraft carrier. Infect Dis Now. 2023;53(4):104673. https://doi.org/10.1016/j.idnow.2023.104673
  20. Salmon D, Slama D, Linard F, et al. Patients with Long COVID continue to experience significant symptoms at 12 months and factors associated with improvement: A prospective cohort study in France (PERSICOR). Int J Infect Dis. 2023;140:9-16.  https://doi.org/10.1016/j.ijid.2023.11.038
  21. Vorobyeva NM, Tkacheva ON, Kotovskaya YuV, et al. Russian epidemiological study EVKALIPT: protocol and basic characteristics of participants. Russian Journal of Geriatric Medicine. 2021;1(5):35-43. (In Russ.). https://doi.org/10.37586/2686-8636-1-2021-35-43
  22. Mkhitaryan EA, Vorobieva NM, Tkacheva ON, et al. The prevalence of cognitive impairment and their association with socioeconomic, demographic and anthropometric factors and geriatric syndromes in people over 65 years of age: data from the Russian epidemiological study EVKALIPT. Nevrologiya, Neiropsikhiatriya, Psikhosomatika. 2022;14(3):44-53. (In Russ.). https://doi.org/10.14412/2074-2711-2022-3-44-53
  23. Titova NV, Bezdolny YuN, Katunina EA. Asthenia, mental fatigue and cognitive dysfunction. Zhurnal Nevrologii i Psikhiatrii im S.S. Korsakova. 2023;123(5):38-47. (In Russ.). https://doi.org/10.17116/jnevro202312305138
  24. Secades JJ. Citicoline: pharmacological and clinical review, 2010 update. Rev Neurol. 2011;52(suppl 2):S1-S62. 
  25. Secades JJ. Citicoline: pharmacological and clinical review, 2016 update. Rev Neurol. 2016;63(S03):S1-S73. 
  26. Plataras C, Taskiris S, Angelogianni P. Effect of CDP-choline on brain acetylcholinesterase and Na+/K+-ATPase in adult rats. Clin Biochem. 2000;33:351-357.  https://doi.org/10.1016/s0009-9120(00)00084-9
  27. Shavlovskaya OA, Bokova IA. Recognan (citicoline) efficacy and safety in cognitive impairment correction of various nosological forms. Zhurnal Nevrologii i Psikhiatrii im S.S. Korsakova. 2023;123(11):22-28. (In Russ). https://doi.org/10.17116/jnevro202312311122
  28. Nemkova SA, Semenov DV, Petrova EA, et al. Cognitive and emotional disorders in university students and teachers: the possibility of treatment with recognan (citicoline). Zhurnal Nevrologii i Psikhiatrii im S.S. Korsakova. 2018;118(12):11-18. (In Russ.). https://doi.org/10.17116/jnevro201811812111
  29. Nemkova SA, Semenov DV, Petrova EA, et al. Current treatment options for autonomic, cognitive and emotional disorders in patients with asthenic syndrome treated with recognan (citicoline). Zhurnal Nevrologii i Psikhiatrii im S.S. Korsakova. 2019;119(7):27-34. (In Russ.). https://doi.org/10.17116/jnevro201911907127
  30. Nemkova SA, Semenov DV, Zavadenko NN, Vozvyshaeva MYu. Features of positive personality phenomena in patients with mild cognitive impairment and asthenic syndrome treated with recognan (citicoline). Zhurnal Nevrologii i Psikhiatrii im S.S. Korsakova. 2020;120(1):44-50. (In Russ.). https://doi.org/10.17116/jnevro202012001144
  31. Nemkova SA, Semenov DV, Zavadenko NN, Vozvyshaeva MYu. The influence of the drug recognan (citicoline) on neurodynamic characteristics of mental activity in patients with mild cognitive impairment. Zhurnal Nevrologii i Psikhiatrii im S.S. Korsakova. 2021;121(1):43-46. (In Russ.). https://doi.org/10.17116/jnevro202112101143
  32. Nemkova SA, Semenov DV, Petrova EA, et al. The effect of the use of the drug Recognan (Citicoline) on the state of higher mental functions in patients with mild cognitive impairment. Zhurnal Nevrologii i Psikhiatrii im. S.S. Korsakova. 2021;121(9):51-57. (In Russ.). https://doi.org/10.17116/jnevro202112109151
  33. Ivonina NA, Petrov KB. The use of neurotropic therapy in young patients with postcovid syndrome. Zhurnal Nevrologii i Psikhiatrii im. S.S. Korsakova. 2022;122(3):126-130. (In Russ.). https://doi.org/10.17116/jnevro2022122031126
  34. Shuteeva TV. The use of neipilept in treatment of asthenic syndrome. Zhurnal Nevrologii i Psikhiatrii im S.S. Korsakova. 2018;118(2):81-84. (In Russ.). https://doi.org/10.17116/jnevro20181182181-84

Email Confirmation

An email was sent to test@gmail.com with a confirmation link. Follow the link from the letter to complete the registration on the site.

Email Confirmation

We use cооkies to improve the performance of the site. By staying on our site, you agree to the terms of use of cооkies. To view our Privacy and Cookie Policy, please. click here.